Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Block

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Methods in Molecular Medicine|February 6, 2004
Enhancement of infection of HepG2 cells in culture by predigestion of hepadnavirus with V8 proteaseXuanyong Lu, Timothy M Block
Disease Markers|January 8, 2009
Fucosylated glycoproteins as markers of liver diseaseAnand Mehta, Timothy M Block
Hepatology (Baltimore, Md.)|March 25, 2018
Do hepatitis B virus surface antigens have any role in viral carcinogenesis?Ju-Tao Guo, Timothy M Block
Gastroenterology|November 29, 2015
The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in "Site"?Timothy M Block, Ju-Tao Guo
Clinical Liver Disease|April 17, 2019
Disease Pathways and Mechanisms of Potential Drug TargetsMarc G Ghany, Timothy M Block
Biotechnology Healthcare|February 12, 2013
Surrogate markers of efficacy for medical treatment of viral hepatitisTimothy M Block, W Thomas London
Antiviral Research|October 9, 2025
Small molecule HBV RNA destabilizing drugs: Drugs of the future or compounds from the past?Timothy M Block, Dimitar Gotchev, Yanming Du
Clinics in Liver Disease|November 6, 2007
Molecular virology of hepatitis B virus for cliniciansTimothy M Block, Haitao Guo, Ju-Tao Guo
Antiviral Research|October 18, 2012
The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapyJinhong Chang, Timothy M Block, Ju-Tao Guo
Antiviral Research|June 27, 2015
Chronic hepatitis B: A wave of new therapies on the horizonTimothy M Block, Siddhartha Rawat, Carol L Brosgart
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Methods in Molecular Medicine|February 6, 2004
Enhancement of infection of HepG2 cells in culture by predigestion of hepadnavirus with V8 proteaseXuanyong Lu, Timothy M Block
Disease Markers|January 8, 2009
Fucosylated glycoproteins as markers of liver diseaseAnand Mehta, Timothy M Block
Hepatology (Baltimore, Md.)|March 25, 2018
Do hepatitis B virus surface antigens have any role in viral carcinogenesis?Ju-Tao Guo, Timothy M Block
Gastroenterology|November 29, 2015
The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in "Site"?Timothy M Block, Ju-Tao Guo
Clinical Liver Disease|April 17, 2019
Disease Pathways and Mechanisms of Potential Drug TargetsMarc G Ghany, Timothy M Block
Biotechnology Healthcare|February 12, 2013
Surrogate markers of efficacy for medical treatment of viral hepatitisTimothy M Block, W Thomas London
Antiviral Research|October 9, 2025
Small molecule HBV RNA destabilizing drugs: Drugs of the future or compounds from the past?Timothy M Block, Dimitar Gotchev, Yanming Du
Clinics in Liver Disease|November 6, 2007
Molecular virology of hepatitis B virus for cliniciansTimothy M Block, Haitao Guo, Ju-Tao Guo
Antiviral Research|October 18, 2012
The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapyJinhong Chang, Timothy M Block, Ju-Tao Guo
Antiviral Research|June 27, 2015
Chronic hepatitis B: A wave of new therapies on the horizonTimothy M Block, Siddhartha Rawat, Carol L Brosgart
Pageof 14